/CRON

CRON Stock - Cronos Group Inc.

Q: What is the analyst price target for CRON?

Analyst price target information is not currently available for CRON.

Q: What is CRON's market cap?

Market capitalization information is not currently available for CRON.

Healthcare|Drug Manufacturers - Specialty & Generic|NASDAQ

$2.70+0.75%

+$0.02 (+0.75%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

High Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+27.0%upside

Target: $3.43

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CRON

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.06

52W High$3.43

52W Low$1.60

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$117.61M	$87.24M	$86.75M	$64.56M	$46.72M
Gross Profit	$25.20M	$11.91M	$15.44M	$-17,593,000	$-25,833,000
Gross Margin	21.4%	13.7%	17.8%	-27.3%	-55.3%
Operating Income	$-76,529,000	$-84,800,000	$-111,428,000	$-291,969,000	$-219,387,000
Net Income	$41.08M	$-73,963,000	$-168,734,000	$-396,107,000	$-73,137,000
Net Margin	34.9%	-84.8%	-194.5%	-613.5%	-156.5%
EPS	$0.11	$-0.19	$-0.45	$-1.07	$-0.21

Company Overview

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Visit Website

Earnings History & Surprises

CRON

Beat Rate

18%

Last 17 quarters

Avg Surprise

-98.3%

EPS vs Estimate

Beats / Misses

3/12

2 met exactly

Latest EPS

$0.07

Q4 2025

EPS Surprise History

Q1 24

-233.3%

$-0.05vs$-0.01

Q2 24

-25.0%

$-0.01vs$-0.01

Q3 24

-700.0%

$-0.02vs$-0.00

Q4 24

-300.0%

$-0.02vs$-0.01

Q1 25

0.0%

$-0.01vs$-0.01

Q2 25

+378.6%

$0.02vs$-0.01

Q3 25

-400.0%

$-0.10vs$-0.02

Q4 25

+250.0%

$0.07vs$0.02

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 6, 2026	—	—	—	—
Q1 2026	Feb 26, 2026	$0.01	—	—	—
Q4 2025	Nov 6, 2025	$0.02	$0.07	+250.0%	✓ BEAT
Q3 2025	Aug 7, 2025	$-0.02	$-0.10	-400.0%	✗ MISS
Q2 2025	May 8, 2025	$-0.01	$0.02	+378.6%	✓ BEAT
Q1 2025	Feb 27, 2025	$-0.01	$-0.01	0.0%	= MET
Q4 2024	Nov 12, 2024	$-0.01	$-0.02	-300.0%	✗ MISS
Q3 2024	Aug 8, 2024	$-0.00	$-0.02	-700.0%	✗ MISS
Q2 2024	May 9, 2024	$-0.01	$-0.01	-25.0%	✗ MISS
Q1 2024	Feb 29, 2024	$-0.01	$-0.05	-233.3%	✗ MISS
Q4 2023	Nov 8, 2023	$-0.00	$-0.00	-100.0%	✗ MISS
Q3 2023	Aug 8, 2023	$-0.01	$-0.02	-68.8%	✗ MISS
Q2 2023	May 9, 2023	$-0.04	$-0.03	+25.0%	✓ BEAT
Q1 2023	Feb 28, 2023	$-0.05	$-0.14	-180.0%	✗ MISS
Q4 2022	Nov 7, 2022	$-0.06	$-0.07	-16.7%	✗ MISS
Q3 2022	Aug 9, 2022	$-0.05	$-0.05	0.0%	= MET
Q2 2022	May 10, 2022	$-0.08	$-0.09	-12.5%	✗ MISS
Q1 2022	Mar 1, 2022	$-0.10	$-0.36	-260.0%	✗ MISS
Q1 2022	Feb 18, 2022	—	$0.16	—	—
Q3 2021	Aug 6, 2021	$-0.07	$-0.09	-28.6%	✗ MISS

Frequently Asked Questions about CRON

What is CRON's current stock price?

Cronos Group Inc. (CRON) is currently trading at $2.70 per share. The stock has moved +0.75% today.

What is the analyst price target for CRON?

The average analyst price target for CRON is $3.43, based on 1 analyst.

What sector is Cronos Group Inc. in?

Cronos Group Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.

What is CRON's market cap?

Cronos Group Inc. has a market capitalization of $1.03 billion, making it a small-cap company.

Does CRON pay dividends?

No, Cronos Group Inc. does not currently pay a dividend to shareholders.